Navigation Links
Low-dose Aspirin Beats High-dose After Cardiac Surgery

The use of medicines to fight cardiovascular disease has been a primary focus of research in this area for the past several decades,// as combinations of interventions and medicinal therapy have gradually begun to increase long-term survival rates.

Two studies has looked at the measurable impact of the use of aspirin and other maintenance therapies, and one demonstrates that lower doses of therapies may prove to be just as beneficial while also lowering side effects.

"Cardiovascular disease is the leading cause of death today, and the major focus of research is to find better ways to help these patients through prevention, immediate intervention and long-term treatment regimens," said Douglas P. Zipes, M.D., Distinguished Professor of the Indiana University School of Medicine. "As we continue to discover the benefits of these therapies, we expect to see continued and measurable improvements in overall survival and quality of life."

After patients with acute coronary syndromes (ACS, a group of symptoms related to acute ischemia, or chest pain related to arterial damage) undergo percutaneous coronary interventions (PCI, including stenting), a significant concern among cardiologists is the risk of major internal bleeding. Aspirin (ASA) acts as a blood thinner to prevent clotting complications, but high levels can cause potentially serious bleeding. While PCI trials have traditionally used high-dose ASA (more than 200 mg) in combination with other medicines to prevent thrombosis and ischemic events, a sub-analysis from a clinical trial presented by researchers at McMaster University in Hamilton, Ontario suggests that low-dose aspirin may be just as effective as high doses to prevent thrombosis while reducing the risk of major bleeding in patients who have undergone PCI.

As a sub-analysis of the PCI-CURE study, researchers compared the safety and efficacy of varying doses of aspirin: low (less than 100 mg), intermediate
'"/>




Page: 1 2 3

Related medicine news :

1. Low-dose Growth Hormone (GH) with diet and exercise may help weight loss
2. Low-dose Aspirin Benefits Both Sexes
3. Low-dose Omega-3 Linked to Lower Blood Pressure
4. Clinical Trials for a Low-dose Steroid Therapy for Bone Marrow Cancer Prove Positive
5. What happens when Asthmatics consume Aspirin?
6. Aspirin reduces deaths
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Aspirin - a drug after one’s own hear
9. Aspirin deflated
10. Aspirin surpasses Modern Anti-clotting Drugs
11. Night Time Aspirin Regimen Found to Reduce Blood Pressure
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...t genes from the saliva may be the biomarkers that... in people. These biomarkers are called salivary ...a. The researchers have been able to successfully ...e out of ten people. The UCLA team has developed w...
...ng seems to be entrenched in the brain development...itute for Neurological Research, Buenos Aires, Arg...rs may not be able to help but gamble. According t...the decision making abilities of 11 spontaneous ga...
...ula with or without breast feeding, weight gain in...obesity, says a current study. Babies who are rais...in from the first week after birth only. This weig...y lead to a strong tendency of becoming obese for ...
...asing waistline, along with the elevated levels of...erogenesis and cardiac problems for post menopausa....5 yrs to estimate the risk of cardiovascular mor...genesis. Atherogenesis is the process of plaques e...
Other Medicine News:
(Date:10/10/2008)...Oct. 10 /- TriReme Medical Inc. (TMI)...fix the CE (Conformite,Europeenne) marking and com...t System, a unique main vessel stent system specia...ons., Representing the next generation in bifurca...l use in a quarter of the 2.2 million,angioplasty ...
(Date:10/9/2008)...l Science Institute, Navigenics, Affymetrix and,Mi...DIEGO, Oct. 9 /- A consortium of heal...ed forces in a first-of-its-kind,research study to...testing,on people who choose to receive such scree...ing certain diseases., Sponsored by Scripps Trans...
(Date:10/8/2008)...ute Pioneers Research That May Offer New Hope to,H...e/ -- Nationally, over 3,000 people are,waiting fo...dly, only half,of those will receive a transplant....te (AHI) is paving the way for how to treat conges...ultimedia News Release, go to:, http://www.prnewsw...
(Date:10/8/2008)... /- Vical Incorporated (Nasdaq: VICL...new nonclinical data,demonstrating that the compan...e in DNA- and protein-based infectious disease vac...Rolland, Pharm.D., Ph.D., Vical,s,Senior Vice Pres...a today,Wednesday, October 8, at the World Vaccin...
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5NanoLogix Inc to Present at EBW Expo 26 Conference 2007 786 1NanoLogix Inc to Present at EBW Expo 26 Conference 2007 786 2New dinosaur species found in Montana 526 1New dinosaur species found in Montana 526 2LMS integrated obstetrics solution achieves general availability 1823 1LMS integrated obstetrics solution achieves general availability 1823 2Cristina Saralegui Joins Celebrities Including Matthew McConaughey Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research 1818 1Cristina Saralegui Joins Celebrities Including Matthew McConaughey Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research 1818 2
...swire/ -- Researchers at,the Medical University of...of a two-year study, which tested the long-term,an...ion),Therapy(TM) in patients with treatment-resist...George, M.D., MUSC Distinguished,Professor of Psyc...or, will appear in the April 2007 issue of the Int...
...RNewswire/ -- Scientists,at WEHI have made a disco...e care of patients, especially those undergoing,ca...Benjamin Kile and David Huang has,discovered that ...les. The discovery raises the prospect of developi...s stored in blood banks,effectively increasing th...
Other Medicine Technology:MUSC Research Offers Hope for Those Resistant to Depression,Treatment 2Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span 2Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span 3
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
STA Compact is a fully automated random access coagulation analyser for clotting, photometric and immunological, latex based .coagulation tests.The medium-throughput analyser offers continous loading
Medicine Products: